TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Participant retention in study assessments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Subjective feelings of loneliness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feelings of social isolation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Perception of social support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perfused Vessel Density (PVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Depression Rating Scales
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mutations in druggable oncogenic pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Activity of the PI3K signaling pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of successfully identified participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Participants Who Received Referrals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in hypoglycemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Radiotherapy Response Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Subjects That Were Diagnosed for Peri-operative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Flow mediated dilation of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bone remodeling of the buccal and palatal walls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate, Severity and Relatedness of reported Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in General Self-Efficacy Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depression and Anxiety Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Premenstrual Tension Syndrome Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Hormone Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Participants With Grade 3 or Higher Toxicity Related to CAR T Cells
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Adjudicated Pulmonary Exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in mHLA-DR expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Validation of the SCOUT DS algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sustained and Significant Reduction in Plasma Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-PRP Antibody Concentrations Greater Than or Equal to 0.15 Microgram Per Milliliter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MenC Antibody Titers Greater Than or Equal to 1:8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MenY Antibody Titers Greater Than or Equal to 1:8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Patients with GERD and/or Eosinophilic Esophagitis (EoE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mucosal impedance values correspond with histopathologic diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Compliance with recommendations for intraoperative temperature management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with recommendations for intraoperative blood glucose management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Usability of the Anesthesiology Control Tower (ACT) for an operating suite
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in knee pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Positive and negative diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Continuous Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Enhanced Liver Fibrosis Score (ELF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NAFLD Fibrosis Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to MRSA Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Morbid-mortality rate at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Presence of myocardial fibrotic change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average intermuscular distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants with unanticipated adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of Colon Preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Response Rate (Complete Response or Partial Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in A1c Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Hypoglycemic Events
Endpoint domain: Adverse events/effects
Primary endpoint: length of stay in the recovery room
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: pericardial effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pulmonary oedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventilatory threshold (VTH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T cell expansion to 1x10^10 HER2 specific T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of infusing HER2 specific T cells
Endpoint domain: Adverse events/effects
Primary endpoint: Count of Participants Who Completed the Study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cadence (steps/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monitor validation (difference in steps/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of PEP005 Topical Gel
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Infusion Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in McGill Pain Questionnaire - Short Form
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change from baseline in Chronic Pain Acceptance Questionnaire - Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in Pain Catastrophizing Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in Tampa Scale for Kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline in Pittsburgh Sleep Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Attempts to insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Global Response (Clinical and Microbiological Success or Failure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of EPO antibody-mediated Pure Red Cell Aplasia (PRCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of children receiving prompt effective treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Motor and Strength Outcome Measure Using Box and Block Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor and Strength Outcome Measure Using Fugl-Meyer Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TGF beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: sIgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL -10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TNF alfa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: LBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Resting Systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Metabolic Equivalent (METS) Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Growth Hormone Secretion Area Under the Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Gene expression in whole blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants cured of head lice infestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Global psychology functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Metabolites in plasma indicative of autism spectrum disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severity of Device and Procedure Related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of immunological test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Specificity of immunological test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Likelihood ratios of immunological test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Position changes between planned and achieved implant position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from Baseline Gray Matter Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fibrosis stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Invasive Fungal Infections
Endpoint domain: Adverse events/effects
Primary endpoint: 12-hour area under the time concentration curve of everolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression Free Survival at 12 Months
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients with undetectable SARS-CoV-2 PCR and CRP < 27 mg/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: culture-conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of post-operative air leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of AD 32 (valrubicin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Female Sexual Function Index (FSFI) - Female Version (QS-F)
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Maximal HO-1 and sirtuin mRNA expression in PBMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychological assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Salivary bacterial level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ctDNA measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mosquito infectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gene Expression in Breast Epithelial Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants Discontinuing Study Treatment Due to TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio of total sleep time over time in bed
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Infant Adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fetal Abdominal Circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated Fetal Weight Percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contraceptive efficacy (pregnancy rate)
Endpoint domain: Mortality/survival
Primary endpoint: Change from Baseline in Shoulder Pain and Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients without arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in symptoms intensity measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of maternal and paternal allelic transmission for risk alleles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IOL A-constant at 3 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical recurrence free survival
Endpoint domain: Mortality/survival
Primary endpoint: Pathological persistence
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of ocular serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to New Foot Complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac Safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Quality of life (QLS total score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of Micro-vascular Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Prevalence of Macro-vascular Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Prevalence of Growth Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional networks of brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Physical Function Test for ICU-scored (PFIT-s)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pittsburgh Rehabilitation Participation Scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Steady State Clonidine Blood Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of Morphine Given
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Physicians Global Assessment (PGA) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful outcome at 12 weeks after voriconazole use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants Receiving INCB059872 Monotherapy With Any Treatment-emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Receiving INCB059872 Combination Therapy With Any TEAE
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio of Urine Protein to Creatine Ratio (UPCR) at 9 Months Compared to Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Ratio of Estimated Glomerular Filtration Rate (eGFR) at 9 Months Compared to Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Zarit Burden Interview
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Modified Rankin scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of adverse events after ALTARGO treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of Contrast Used
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Outcome response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Public Speaking Anxiety Scale Post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Public Speaking Anxiety Scale at 1-week
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in scores on Behaviour Rating Inventory of Executive Functioning (BRIEF)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Suffering
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of caries prevented
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life of children
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of Participants Without MR Scan-related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Success Rate for Threshold Measurement at 1 Month Post-MRI Scan or Control Group Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success Rate for Sensed Amplitude Measurement at 1 Month Post-MRI Scan or Control Group Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of elbow contracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Nutrition knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Physical activity knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Nutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of adverse events (AEs) for single dose
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse events (AEs) for multiple dose
Endpoint domain: Adverse events/effects
Primary endpoint: Evolution of respiratory specific health related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Evolution of generic health related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Blood troponin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute cardiovascular event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under curve for total 14C labelled PRC-4016 in whole blood and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration of 14C labelled PRC-4016 (icosabutate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantifying urinary and faecal excretion of 14C labelled PRC-4016
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct-go Reaction Time (RT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to Startle Reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Measures of Level of Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under the concentration-time curve (AUC) from time of dosing to the last quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from the time of dosing extrapolated to time infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Anaesthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline on the Adaptive Behavior Assessment System (ABAS) Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Dopamine D2 Receptor Occupancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of solicited local adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of solicited systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Pulse rate at each visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure(systolic/diastolic) at each visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Body temperature at each visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dosage of cytokines and chemokines in plasma samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pre-delivery Hospitalization Time
Endpoint domain: Resource use
Endpoint subdomain: Hospital